Page last updated: 2024-12-07

alpha-(difluoromethyl)arginine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Alpha-(difluoromethyl)arginine (DFMA) is a potent and selective inhibitor of arginase, an enzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. DFMA has been shown to inhibit arginase activity in vitro and in vivo. The synthesis of DFMA typically involves a multi-step process starting from L-arginine. DFMA has been investigated for its potential therapeutic effects in various diseases, including cancer, inflammation, and cardiovascular disease. Arginase inhibition by DFMA can enhance the production of nitric oxide (NO), a signaling molecule with vasodilatory and anti-inflammatory properties. DFMA is studied because of its potential to modulate arginine metabolism and alter the balance between NO production and arginase activity. Its effects on the immune system, cardiovascular system, and wound healing are also areas of active research.'

alpha-(difluoromethyl)arginine: irreversible inhibitor of arginine decarboxylase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121939
SCHEMBL ID10668232
MeSH IDM0097661

Synonyms (27)

Synonym
alpha-(difluoromethyl)arginine
FT-0666834
77286-88-5
n5-(diaminomethylidene)-2-(difluoromethyl)ornithine
2-amino-5-(diaminomethylideneamino)-2-(difluoromethyl)pentanoic acid
2-(difluoromethyl)arginine
69955-43-7
2-difluoromethylarginine
arginine, 2-(difluoromethyl)-
dl-alpha-(difluoromethyl)arginine
dl-|a-(difluoromethyl)arginine
2-difluoromethyl-2-amino-5-guanidinopentanoic acid
SCHEMBL10668232
AKOS030255526
a-difluoromethylarginine
??-(difluoromethyl)-dl-arginine
AKOS030589951
2-amino-5-carbamimidamido-2-(difluoromethyl)pentanoic acid
DTXSID00990215
2-amino-2-(difluoromethyl)-5-guanidinopentanoic acid
2-(difluoromethyl)arginine 100 microg/ml in water
dl-?-(difluoromethyl)arginine
dl- alpha -(difluoromethyl)arginine
.alpha.-(difluoromethyl)-dl-arginine
2-amino-2-(difluoromethyl)-5-guanidinopentanoicacid
CS-0138494
HY-134161
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (55.26)18.7374
1990's11 (28.95)18.2507
2000's5 (13.16)29.6817
2010's1 (2.63)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.37 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.04 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]